Arcus Biosciences Inc (RCUS) stock saw a decline, ending the day at $15.31 which represents a decrease of $-0.08 or -0.52% from the prior close of $15.39. The stock opened at $15.19 and touched a low ...

Rashford put in one of his best performances of the season against Porto before being taken off by Erik ten Hag for rotation ...

US clinical-stage biotech Arcus Biosciences has entered into a clinical trial collaboration with AstraZeneca on renal cancer ...

Hitsuji began serializing the The Magician Who Rose From Failure: Tales of War and Magic story on the "Shōsetsuka ni Narō" ...

Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform ...

DTCP has invested in Atlantic Hub, a data center developer in Ireland, spotting an opportunity away from more well-trodden ...

"Arcus and AstraZeneca enter trial collaboration for renal cancer treatment" was originally created and published by Clinical ...

FixMap is an “M&A machine” and the leading player in the Polish fiber-to-the-home (FTTH) market by far, thanks to the ...

Improving oilseed crop yields is critical. India ranks fourth globally in soybean acreage but is only fifth in productivity.

Wednesday announced a clinical trial collaboration agreement with AstraZeneca (AZN) to evaluate casdatifan in combination with volrustomig for the treatment of clear cell renal cell carcinoma or ccRCC ...

Arcus Biosciences Announces Clinical Trial Collaboration Agreement to Evaluate Casdatifan in Combination with Volrustomig in ...

CNW/ - Arcus Power, an energy intelligence company, today announced a strategic partnership with weather tech pioneer ...